The Biotech Growth Trust PLC

BIOG

GB0000385517

Investment Trusts

Market Closed - London S.E. Other stock markets 16:35:01 13/05/2026 BST			5-day change	1st Jan Change
1,358.00 ^GBX	+0.89%		+1.04%	+13.17%

05-06	BIOG's investee Esperion bought by ArchiMed for USD1 billion	AN
05-05	BioPharma Credit to Finance Archimed's Purchase of Biotech Growth Trust's Esperion Therapeutics	MT

Biotech Growth Trust says while outlook is encouraging, challenges remain

Published on 11/20/2025 at 08:08 am GMT

Reuters

This article is reserved for members

Unlock the article: REGISTER NOW!

100% Free Registration

Already a customer? Log In

Latest news about The Biotech Growth Trust PLC

05-06	BIOG's investee Esperion bought by ArchiMed for USD1 billion	AN
05-05	BioPharma Credit to Finance Archimed's Purchase of Biotech Growth Trust's Esperion Therapeutics	MT
05-01	The Biotech Growth Trust plc Archimed to acquire Biog Portfolio Company, Esperion Therapeutics.	RE
05-01	Archimed to Acquire Biotech Growth Trust Portfolio Co Esperion for $1 Billion	MT
04-01	Apellis investors respond to USD5.60 billion Biogen acquisition	AN
12-22	The Biotech Growth Trust Biomar Pharmaceuticals to acquire Biog portfolio company, Amicus Therapeutics	RE
11-20	Biotech Growth Trust says while outlook is encouraging, challenges remain	RE
11-20	The Biotech Growth Trust PLC Reports Earnings Results for the Half Year Ended September 30, 2025	CI
11-14	The Biotech Growth Trust PLC commences an Equity Buyback Plan for 2,710,338 shares, representing 14.90% of its issued share capital, under the authorization approved on November 12, 2025.	CI
17/09/25	Biotech Growth Trust appoints former UKHSA head Jenny Harries to board	AN
20/08/25	Biotech Growth Trust says court confirms capital reduction	AN
05/06/25	Saturn Oil & Gas Inc.'s Board intends to launch an Equity Buyback.	CI
04/06/25	Biotech Growth Trust director buys GBP75,000 in shares	AN
04/06/25	Biotech Growth Trust underperforms benchmark as net asset value falls	AN
04/06/25	The Biotech Growth Trust PLC Reports Earnings Results for the Full Year Ended March 31, 2025	CI

Chart The Biotech Growth Trust PLC

Duration

Period

BIOG: Dynamic Chart

The Biotech Growth Trust PLC is a United Kingdom-based externally managed investment trust. The Company's investment objective is to seek capital appreciation through investment in the biotechnology industry across the world. It invests in a diversified portfolio of shares and related securities in biotechnology companies on a worldwide basis. The Company invests more than 10%, in aggregate, of the value of its gross assets in other closed-end investment companies (including investment trusts) listed on the London Stock Exchange. The Company invests more than 15% of the value of its gross assets in any one individual stock at the time of acquisition. Its portfolio of investments across various countries includes the Netherlands, the United States of America, Canada, and China. The Companyâ€™s alternative investment fund manager is Frostrow Capital LLP.

Employees

Sector

Investment Trusts

Calendar

Earnings release - Annual 2026

More about the company